Skip to main content

Open Access 07.05.2024 | Original Communication

Visuospatial working memory in behavioural variant frontotemporal dementia: a comparative analysis with Alzheimer's disease using the box task

verfasst von: David Foxe, Muireann Irish, James Carrick, Sau Chi Cheung, Her Teng, James R. Burrell, Roy P. C. Kessels, Olivier Piguet

Erschienen in: Journal of Neurology

Abstract

Objective

This study investigated the visuospatial working memory profiles of behavioural variant frontotemporal dementia (bvFTD) and Alzheimer’s disease (AD) using a novel computerised test of visuospatial working memory: the Box Task.

Methods

Twenty-eight bvFTD and 28 AD patients, as well as 32 age-matched control participants were recruited. All participants completed the Box Task and conventional neuropsychological tests of working memory, episodic memory, and visuospatial function.

Results

Both the bvFTD and AD groups exhibited significantly more Box Task between-search errors than the control group across all set sizes. Notably, the AD group demonstrated a significantly higher error rate compared to the bvFTD group. Regression analysis revealed that whilst episodic memory impairment significantly predicted Box Task error performance in AD, this was not the case for bvFTD. Additionally, a noticeable trend was observed for attention in predicting Box Task errors in both bvFTD and AD groups. The Box Task demonstrated high utility in differentiating between bvFTD and AD, with a decision tree correctly classifying 82.1% of bvFTD patients and 75% of AD patients.

Conclusions

Our findings reveal significant visuospatial working memory impairments in bvFTD, albeit of lesser severity compared to disease-matched AD patients. The Box Task, a novel measure of visuospatial working memory, proved effective in differentiating between bvFTD and AD, outperforming many traditional neuropsychological measures. Overall, our findings highlight the utility of assessing visuospatial memory when differentiating between bvFTD and AD in the clinical setting.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00415-024-12406-0.

Introduction

The memory profile of the behavioural variant of frontotemporal dementia (bvFTD) has been a subject of debate [13]. The current consensus criteria for bvFTD describe a neuropsychological profile of relatively intact episodic memory and visuospatial abilities in the context of marked executive dysfunction [4]. Recent research, however, demonstrates the presence of significant episodic memory disturbances in the early stages of bvFTD [3, 57]; similarly, visuospatial deficits have also been documented [8, 9]. As such, ambiguity remains surrounding the early neuropsychological profile of bvFTD [1, 2] prompting a growing interest in understanding how cognitive processes, such as visuospatial working memory, are impacted [3, 10].
In contrast to bvFTD, Alzheimer's disease (AD) is characterised by prominent deficits in both memory and visuospatial abilities [3, 7, 11, 12]. Extensive literature on AD emphasises the disproportionate impairment of visuospatial memory and underscores its utility in differentiating AD from other dementias, including bvFTD [3, 13]. There has, however, been less emphasis in exploring whether visuospatial working memory could serve as a clinical marker for distinguishing AD from bvFTD [10, 14]. Visuospatial working memory involves the capacity to temporarily store and manipulate visual and spatial information in mind (i.e., over a few seconds), and is crucial for forming longer-term memories [15, 16]. Whether alterations in visuospatial working memory could serve as a distinctive clinical marker for discriminating between bvFTD and AD remains unclear [10, 14].
In this study, we examined the visuospatial working memory profiles of individuals with bvFTD and AD using a novel computerised test—the Box Task [17]. The Box Task is an associative working memory task that involves binding information between objects and their spatial location, a process that is particularly impaired in AD [1719]. Compared to conventional visuospatial memory tests, the Box Task investigates different dimensions concurrently, such as error types, efficiency of strategy search, and provides graded levels of impairment. Based on previous literature [3, 7, 10, 13, 18, 19], we hypothesised that both bvFTD and AD would demonstrate visuospatial working memory deficits, relative to healthy participants. Importantly, however, we predicted that AD patients would perform worse on the Box Task relative to bvFTD patients. To identify potential mechanisms driving Box Task performance, we also assessed visuospatial, memory, and non-verbal abilities. We hypothesised that visuospatial memory impairment would largely predict Box Task error performance in AD, while attentional and executive impairment would predict error performance in bvFTD [10]. To evaluate its diagnostic utility, we compared the Box Task to other cognitive measures typically used to distinguish between bvFTD and AD. Finally, we provide a Box Task decision tree to assist clinicians in using this tool in the differential diagnosis of bvFTD and AD.

Methods

Participants

Fifty-six patients diagnosed with dementia (probable AD: 28, probable bvFTD: 28) and 32 healthy controls were recruited between September 2015 and December 2020 from FRONTIER, the younger-onset dementia research clinic based at the Brain and Mind Centre at the University of Sydney, Australia. Patients underwent a comprehensive clinical evaluation with an experienced neurologist, a neuropsychological assessment, and a structural brain MRI scan. The clinical assessment and MRI scan occurred within 3 months of the neuropsychological assessment. Diagnosis was established according to current clinical diagnostic criteria for probable bvFTD [4] and probable ‘amnestic’ (i.e., typical) AD [11]. Disease duration was characterised as the time (years) of diagnosis from the onset of symptoms as described by the carer. Patients with non-amnestic presentations of AD (e.g., ‘executive’ AD, ‘language’ AD [incl. logopenic progressive aphasia], ‘visuospatial’ AD [incl. posterior cortical atrophy]) were excluded [11, 20, 21]. Importantly, Box Task performance was not included in the diagnostic process to avoid circularity. Exclusion criteria for all participants (i.e., patients and control participants) included concurrent psychiatric diagnosis, presence of other dementias or neurological syndromes, traumatic brain injury, history of alcohol or substance abuse, poor English proficiency, and/or absence of a reliable informant. Participants were excluded if they scored < 50/100 (for dementia patients) or < 88/100 (for controls) on the Addenbrooke’s Cognitive Examination-III [ACE-III: 22].
All participants or the person responsible provided written informed consent in accordance with the Declaration of Helsinki. The South Eastern Sydney Local Health District, the University of New South Wales, and the University of Sydney human ethics committees approved the study.

General cognition and dementia severity assessment

All participants completed the ACE-III as an index of overall cognitive function [22, 23] and underwent a series of cognitive tests measuring the following cognitive constructs: (i) short-term memory (Spatial and Digit Span forward) [24]; (ii) working memory (Spatial and Digit Span backward); (iii) attention (ACE-III attention subdomain; Trail Making Test Part A) [24]; (iv) executive function (Trail Making Test Part B); (v) episodic memory (ACE-III memory subdomain; Rey Complex Figure Test [RCFT] 3-min recall [25]); (vi) language skills (confrontation naming, single-word repetition, and semantic association subtests of the Sydney Language Battery [26]); (vii) verbal fluency (ACE-III fluency subdomain); and (viii) visuospatial/constructional ability (ACE-III visuospatial subdomain; RCF copy trial [25]).
In addition, spouses, relatives, or carers of patients completed the Disability Assessment for Dementia (DAD [27]). The DAD is an informant-based measure that assesses the patient’s level of functioning in activities of daily living. The total DAD score is reported as a percentage of remaining ability, with lower values representing poorer day-to-day functioning.

The box task

The Box Task is a novel computerised visuospatial working memory task in which pictures of closed boxes are presented at various locations on a computer screen, with increasing set sizes (4, 6 and 8 boxes) (Fig. 1; see Kessels and Postma [17] for information on this task). Briefly, participants are instructed to find a hidden target object by ‘opening’ the boxes on the screen one by one. When a target is found, a new target object is presented that has to be searched. Participants are instructed that the previously found object will remain hidden in its box. Thus, participants are not only required to remember which boxes they recently searched but also which boxes contain previous targets. When all target objects are found, a new trial with a new spatial layout and an increased number of boxes starts. Thus, a trial consists of a set of to-be-searched boxes of a given set size and a given spatial layout in which multiple objects have to be found successively; a search refers to finding the hidden location of the current object. The task includes two practice trials that contain three boxes followed by two trials with 4, 6, then 8 boxes (i.e., two trials at the 4-box set size, two trials at the 6-box set size, etc.). There is no time limit imposed but participants are encouraged to respond within a reasonable time (i.e., within a few seconds).
Two error scores were computed from the Box Task (Fig. 1). First, between-search errors were calculated, denoting when participants returned to a box containing a target previously encountered from a previous search within that trial. This score reflects the ability to maintain object–location information for periods of time ranging from a few seconds to 1–2 minutes. Second, within-search errors were calculated, denoting when participants returned to a box that had already been opened within the current search (i.e., returning to a box that was already found to be empty during that search). This score reflects the ability to keep track of recently searched locations and captures short-term retention of visuospatial information. The time (seconds) to find the hidden location of each object was also recorded. Finally, a normalised Levenshtein edit distance score was computed as a measure of ‘search path strategy’—that is, the participant’s ability to adopt an efficient strategy to complete the task [28]. The normalised Levenshtein edit distance score computes the similarity/difference between two search paths. Briefly, it compares the current search path with the one from the previous search, minus the target from the previous search, resulting in a score ranging from 0–1. In this study, lower distance scores represent a more proficient strategy to complete the task.

Statistical analyses

Data were analysed using IBM SPSS Statistics, 26.0 (SPSS Inc., Chicago, Ill., USA) and figures were created with GraphPad Prism 9 (GraphPad Software, San Diego, CA, USA). Distribution of demographic, neuropsychological, and behavioural data were inspected using Shapiro–Wilks tests. Normally distributed variables were compared across all groups (i.e., bvFTD, AD, controls) using one-way ANOVAs followed by Sidak post hoc tests; T tests were used to compare normally distributed variables across two groups (bvFTD, AD). Variables not normally distributed were analysed using Kruskal–Wallis ANOVA followed by Dunn-Bonferroni post hoc tests. Chi-square tests (χ2) were used to analyse categorical measures (e.g., sex).
Three separate Generalised Estimating Equations (GEE) regression models were used to analyse the Box Task between-error, within-error, and strategy variables. The GEE factors included trial (i.e., two per set size) and set size (i.e., 4, 6, 8 boxes) nested under group (i.e., bvFTD, AD, controls). The participant was included as the subject variable. A Poisson distribution was selected for the between-error GEE as the between-error variable reflected count data, whereas a linear distribution was selected for the within-error and strategy GEEs as these variables reflected scale numeric data. Null hypotheses of no change in all fixed effects were tested. Parameter estimates of the overall group and group by box set size were derived. For the time variable, a set size (i.e., 4, 6, 8 boxes) × group repeated measures mixed model ANOVA was conducted, as the 4-box Trial 1 time was not available due to a computing error (thus GEE modelling could not be conducted). The 4-box Trial 2-time score (only) was analysed along with the respective mean (i.e., average of Trial 1 and 2) for 6-box and 8-box set size time scores. For both GEE and repeated measures mixed model analyses, post hoc pairwise comparisons of groups were analysed using least-significant difference (LSD), with the false discovery rate controlled using the Benjamini–Hochberg procedure [29]. The false discovery rate Q was set at 0.05.
We evaluated the relative contribution of basic visuospatial ability, memory (i.e., short-term, working, episodic), attention, and executive functioning to the Box Task 6-box between-search error scores in bvFTD and AD by conducting two separate multiple regression analyses (enter method). The Box Task 6-box between-search error measure was selected as it was previously shown to evoke an optimal level of cognitive demand and complexity compared to the 4- and 8-box set sizes [18, 19]. For both analyses, the 6-box between-search error score (average error scores over two trials) was the dependent variable and the cognitive test measures (ACE-III visuospatial, WMS-III Spatial Span [forward, backward], RCF copy and 3-min recall, Trails A and B [time and errors]) were the independent variables. The standardised beta coefficient values for each regression model were inspected to determine the contribution (i.e., magnitude of effect) of each cognitive ability on between-search error scores. For executive function, the Trails B minus A time difference score was used rather than Trails B time score due to collinearity concerns with Trails A time.
We inspected the area under the receiver operating characteristic curve (AUC) for all Box Task variables (i.e., average performance over two trials at 4, 6, and 8 box set size) as compared to other cognitive tests of interest to determine the most sensitive measures to differentiate bvFTD from AD patients. Statistical significance for all AUC analyses was set at p < 0.05.
Finally, the chi-square automatic interaction detector (CHAID) method was used to create a decision tree to classify bvFTD versus AD patients based on their ACE-III total (/100) performance (n.b., the first variable forced into the model) and between- and within-search error scores (total score of trial 1 and 2) at each set size (i.e., 4, 6 and 8 boxes). No data from control participants were included in this analysis. The rationale for the variables included in the CHAID model is provided in the Supplementary Material.

Results

Demographics

Groups were comparable for sex (p = 0.169) and age (p = 0.069) but not for years of education (p = 0.019), with the control group having more years of education than the bvFTD group (p = 0.020) (Table 1). Patient groups did not differ in disease duration (p = 0.283) or functional capacity (i.e., DAD total; p = 0.936). An overall group difference was present for general cognitive functioning on the ACE-III total (p < 0.001), driven by better performance in controls relative to the patient groups (all p values < 0.001). Importantly, the bvFTD and AD groups were comparable on the ACE-III total (p = 0.060).
Table 1
Demographic characteristics and cognitive performance of study participants
 
AD
bvFTD
Controls
Group effect (F or H)
p
Post hoc test#
Sex (m: f)
16:12
19:9
14:18
3.552†
.169
 
Age (y)
66 (8.8)
62.4 (8)
66.7 (5.3)
2.764
.069
 
Education (y)
13.2 (2.8)
11.8 (2.6)
13.7 (2.4)
4.13
.019
bvFTD < Controls
Disease duration (y)
3.9 (1.9)
5.0 (2.5)
1.177
0.283
 
DAD total (100)
76.4 (18.2)
51.5 (18.0)
0.007
0.936
 
ACE-III total (100)
68.3 (10.5)
74 (11.7)
95.1 (3)
74.776
 < 0.001
AD, bvFTD < Controls
Visuospatial ability and episodic memory
 ACE-III visuospatial (16)
12.5 (3.4)
14.3 (1.5)
15.4 (0.9)
13.717
 < 0.001
AD < bvFTD, Controls
 RCF copy (36)
24.9 (8.5)
26.2 (7.2)0
31 (4.1)
11.367^
0.003
AD, bvFTD < Controls
 RCF copy time (secs)
282.2 (141.3)
202.4 (123.2)
182.5 (68.7)
11.757^
0.003
AD > bvFTD, Controls
 RCF 3-min recall (36)
3 (3.4)
8.3 (6.8)
16.7 (5)
47.878^
 < 0.001
AD < bvFTD < Controls
Visuospatial short-term and working memory
 Spatial Span forward (16)
5.5 (2.2)
6.4 (2.1)
8 (1.5)
12.741
 < 0.001
AD, bvFTD < Controls
 Spatial Span backward (16)
4.3 (2.5)
5.9 (2.4)
7.5 (1.8)
15.36
 < 0.001
AD < bvFTD < Controls
Values are mean ± standard deviation
Number of missing values: Education = 1 control; DAD = 1 AD, 3 bvFTD; RCF copy = 3 AD; RCF copy time = 3 AD, 1 bvFTD; RCF 3-min recall = 3 AD
ACE-III Addenbrooke’s Cognitive Examination–Third edition, AD Alzheimer’s disease, bvFTD behavioural variant frontotemporal dementia, DAD Disability Assessment for Dementia, Disease duration time (years) of diagnosis from the onset of symptoms as described by the carer, f female, m male, RCF Rey Complex Figure, Spatial Span Spatial Span from the Wechsler Memory Scale—Third Edition, y years
†χ2 test
^Kruskal–Wallis ANOVA
#Sidak corrected for parametric tests, Bonferroni corrected for non-parametric tests

Cognitive profiles of participants

Both dementia groups showed the prototypical cognitive profiles on neuropsychological testing (see Supplementary Material). Notably, the bvFTD group performed comparably to the control group on a basic measure of visuospatial ability (ACE-III visuospatial, p = 0.137), but demonstrated difficulties on a more complex visuoconstructional task (RCF copy score, p = 0.020). Visuospatial episodic memory (RCF 3-min recall, p < 0.001), and visuospatial short-term (Spatial Span forward, p = 0.007) and working memory (Spatial Span backward, p = 0.018) were also impaired in bvFTD relative to controls. In contrast, the AD group displayed impairments on all measures of visuospatial ability (ACE-III visuospatial, p < 0.001; RCF copy score, p = 0.003), visuospatial episodic memory (RCF 3-min recall, p < 0.001) and visuospatial short-term and working memory (Spatial Span forward, p < 0.001; Spatial Span backward, p < 0.001) relative to the control group (Table 1).
Direct comparisons between patient groups indicated greater visuospatial dysfunction (ACE-III visuospatial, p = 0.008), and visuospatial episodic (RCF 3-min recall, p = 0.001) and working memory (Spatial Span backward, p = 0.031) impairment in AD compared with bvFTD. Of note, the AD group was significantly slower than the bvFTD and the control groups at completing the RCF copy task (RCF copy time, both p values ≤ 0.036).

Box Task

Between-search errors

A significant main effect of group was found for between-search errors (p < 0.001) (Table 2; Fig. 2a; Supplementary Table 2), driven by significantly more between-search errors in patients compared to controls overall (both p values < 0.001), as well as across all set sizes (4-box, p values ≤ 0.003; 6-box, p values < 0.001; 8-box, p values < 0.001). Additional comparisons between the patient groups revealed disproportionate impairments in the AD group relative to the bvFTD group on the 4-box (p = 0.002) and 6-box (p = 0.012) set sizes but not on the 8-box set size (p = 0.130) (Table 2).
Table 2
Estimated means and post-hoc group comparisons of the between-search errors, within-search errors, time taken, and strategy score on the Box Task at each set size (i.e., 4, 6, and 8 boxes)
Number of boxes
AD
bvFTD
Controls
Post hoc testa
Between-search errors
 4
2.02 (0.27)
0.97 (0.20)
0.29 (0.1)
AD > bvFTD > Controls
 6
6.29 (0.61)
3.89 (0.74)
1.18 (0.32)
AD > bvFTD > Controls
 8
11.71 (0.96)
9.81 (0.80)
3.55 (0.54)
AD, bvFTD > Controls
Within-search errors
 4
0.04 (0.05)
0.03 (0.02)
0.05 (0.02)
 6
0.32 (0.11)
0.10 (0.04)
0.12 (0.05)
 8
0.42 (0.15)
0.19 (0.07)
0.08 (0.04)
Time (seconds)
 4
72.62 (5.79)
42.39 (5.79)
20.08 (5.41)
AD > bvFTD > Controls
 6
116.46 (9.95)
76.68 (9.95)
35.04 (9.31)
AD > bvFTD > Controls
 8
165.36 (12.03)
122.66 (12.03)
67.97 (11.25)
AD > bvFTD > Controls
Strategy (Levenshtein edit distance)
 4
0.68 (0.04)
0.70 (0.03)
0.59 (0.03)
 6
0.84 (0.02)
0.80 (0.02)
0.71 (0.02)
AD, bvFTD > Controls
 8
0.80 (0.02)
0.81 (0.01)
0.70 (0.02)
AD, bvFTD > Controls
Values are the means (of two trials) ± standard error of the mean. The between-search error, within-search error, and strategy values (and post hoc group comparisons) are derived from the generalised estimating equations modelled data. The time values (and post hoc group comparisons) are derived from the repeated measures mixed model analysis of variance (ANOVA)
aBenjamini-Hochberg corrected
Within-group comparisons revealed all groups made more between-search errors as set size increased (all p values ≤ 0.001) (Supplementary Table 6).

Within-search errors

No significant group differences were found for within-search error scores across all set sizes (all p values ≥ 0.030; not significant after Benjamini–Hochberg corrections) (Table 2; Fig. 2b; Supplementary Table 3). Within-group investigations revealed that the AD group made fewer errors at the 4-box set size than at the 6-box and 8-box set sizes (p values ≤ 0.007) (Supplementary Table 6). No significant differences were observed for the other groups (all p values ≥ 0.044; not significant after Benjamini–Hochberg corrections).

Time to complete the task

Both the bvFTD and AD groups were slower to complete the task relative to the control group across all set sizes (all p values ≤ 0.006) (Table 2 and Fig. 2; see also Supplementary Table 5). In addition, AD patients took significantly longer to complete the task than the bvFTD patients (across set sizes and overall; p values ≤ 0.014). All groups took longer to complete the task as the set size increased (time duration for all groups: 4 boxes < 6 boxes < 8 boxes, all p values < 0.001) (Supplementary Table 6).

Search path strategy (normalised Levenshtein edit distance score)

The normalised Levenshtein edit distance score provides an index of search path strategy efficiency. Relative to controls, search path strategy scores were higher (i.e., less efficient) for patients during overall task completion (both p values < 0.001) and across all set sizes (4-box, p values ≤ 0.003; 6-box, p values < 0.001; 8-box, p values < 0.001) (Table 2; Supplementary Fig. 1; Supplementary Table 4). No significant differences were present between patient groups (p values ≥ 0.621).
Task difficulty was also found to influence search path strategy. Irrespective of group, search path strategy was better at lower levels of task difficulty (i.e., 4-box vs 6-box set size; all p values < 0.003; 4-box vs 8-box set size; all p values ≤ 0.002), with no difference between the higher levels (i.e., 6-box vs 8-box p ≥ 0.111) (Supplementary Table 6).

Contribution of visuospatial and non-verbal abilities to the Box Task 6-box set size performance

Separate mixed regression models demonstrated that conventional visuospatial and non-verbal abilities (as measured by the ACE-III visuospatial subdomain, Spatial Span, RCF, and Trails A and B tests) were significant predictors of between-search error performance at the 6-box set size in AD (full model R2 = 0.511) and bvFTD (full model R2 = 0.593). Standardised beta coefficient values for each mixed regression model revealed distinct profiles across groups (Fig. 3; Supplementary Tables 7 and 8). In the AD group, visuospatial episodic memory (RCF 3-min recall) significantly predicted between-search error performance (p = 0.035) with the suggestion of a non-statistically significant trend for attention (Trails A time) (p = 0.070).
By contrast, in the bvFTD group, visuospatial episodic memory (RCF 3-min recall) did not significantly predict error performance (p = 0.871). Notably, however, attention (Trails A time) was on the threshold of significance (p = 0.053). Interestingly, lower Trails B-A time (i.e., an index of executive functioning) standardised beta coefficient value was related to increased between-search errors on the Box Task.

Discriminating between bvFTD and AD based on Box Task and neuropsychological performance

The AUCs demonstrated that visual episodic memory performance (RCF 3-min recall; AUC 0.771), Box Task 4-box set size time (AUC 0.759), and Box Task 6-box set size between-search error performance (AUC 0.747) were the three most effective measures at discriminating bvFTD from AD, whereby AD performance was consistently worse than bvFTD on these measures (Fig. 4, Supplementary Table 9). Notably, the Box Task error (between-search: 4- and 6-box set sizes; within-search: 6-box set size) and time (all set sizes) measures were broadly more accurate than other conventional neuropsychological measures at differentiating bvFTD from AD (all AUCs > 0.700: 5 Box Task measures, 3 conventional neuropsychology measures). Finally, the AUCs largely confirmed that the AD group experienced greater learning and memory difficulties than the bvFTD group (e.g., Box Task error measures, Spatial Span, RCF, ACE-III memory subdomain).

Classifying AD and bvFTD patients using the Box Task error measures

The CHAID demonstrated that Box Task between- and within-search error scores accurately classified 75% of AD patients (21/28 correctly classified) and 82.1% of bvFTD patients (23/28 correctly classified) (overall percent correct: 78.6%) after taking into account the ACE-III Total score as an index of overall cognitive impairment (≤ 70 vs > 70; n.b., first variable forced in the model). The CHAID model risk estimate was 0.214, indicating a 21% “risk” of misclassifying a patient (CHAID model standard error: 0.055; Fig. 5). For ACE-III scores above 70, the presence of one or more within-search errors (sum of Trials 1 and 2) at the 6-box set size was indicative of AD. For ACE-III scores 70 and below, between-search errors on the 4-box condition became the relevant error score, whereby the presence of 2 or more such errors was strongly suggestive of AD.

Discussion

Mounting evidence indicates that episodic memory is impaired in bvFTD [3, 5, 7]. Using a novel, computerised test, the Box Task, we demonstrate that these impairments extend to the domain of visuospatial working memory. Overall, bvFTD patients displayed significant visuospatial working memory impairment across multiple levels of task difficulty. These impairments, however, were less severe than that observed in AD. Our findings suggest that visuospatial working memory deficits may need to be recognised as a relevant clinical feature of bvFTD. Moreover, our findings indicate that the Box Task offers potential diagnostic value in differentiating bvFTD from AD.
Our main finding was the presence of marked visuospatial working memory disturbances in bvFTD. Relative to controls, the bvFTD group displayed significantly more between-search errors on the Box Task across all levels of task difficulty. Between-search errors involve revisiting a location where an object has already been found and are suggested to reflect a breakdown in binding item and location information, as well as in basic processes such as object recognition and spatial-location processing [17]. Importantly, we found evidence of between-search impairment even at the lowest level of task difficulty (4-box set size), indicating a core disturbance of basic visuospatial memory processes (e.g., lower-load encoding and retention) that are not attributable to task demands. As task difficulty increased (i.e., at the 6- and 8-box set sizes), bvFTD patients made disproportionately more between-search errors than controls—likely reflecting a cumulative breakdown across multiple cognitive processes. In contrast, within-search performance, which requires comparatively lower cognitive demands [17], did not differ significantly among groups. This suggests that the between-search error measure of the Box Task elicits an optimal level of cognitive challenge and complexity compared to the within-search error measure. Taken together, our findings support the view that visuospatial working memory disruption is pervasive in bvFTD [10, 14] and suggest that the current clinical conception of bvFTD [4] may need revision to account for multidimensional memory disturbances spanning short-term, working, and episodic domains [1, 3, 6, 30, 31].
With respect to the AD group, visuospatial working memory was, unsurprisingly, severely compromised. Consistent with prior studies [18, 19], AD patients displayed significantly more between-search errors on the Box Task across all set sizes compared to controls. When compared with the bvFTD group, the AD group displayed significantly more between-search errors on the lower load 4- and 6-box set sizes but were not found to differ on the more cognitively demanding 8-box set size. These findings indicate that performance disparities between bvFTD and AD patients on the Box Task are most pronounced on visuospatial working memory tasks of low-to-moderate difficulty, and in patients with mild-to-moderate stages of dementia (disease duration of 3–5 years). Once task demands exceed a critical threshold (in this case the 6-box set size), patient groups display comparable error levels, suggesting the Box Task may be most useful in dementia diagnostics at lower to medium levels of cognitive demand [19]. Collectively, our Box Task and neuropsychological test findings reinforce the notion that alterations in visuospatial processing and memory dysfunction are core characteristics of AD [7, 1113].
Visuospatial working memory encompasses a complex interplay of various processes, including perception, attention, executive functions, encoding, and short-term storage [3235]. In bvFTD, impaired working memory is theorised to arise from frontal executive dysfunction, involving aspects such as sustained attention, mental flexibility, and response inhibition [10, 14]. Surprisingly, our mixed regression analysis of the Box Task 6-box set size between-search error profiles in bvFTD revealed that disruptions in higher-level executive functions (e.g., Trails Making Test B time) did not significantly predict Box Task error performance. Similarly, characteristics of short-term, working, and episodic memory (Spatial Span, RCF recall) did not significantly predict Box Task errors in bvFTD. Instead, attention (Trails A time) was on the threshold of significance in predicting task performance. In contrast, in the AD group, we had initially predicted that compromised Box Task performance would stem from a short-term capacity problem, encompassing difficulties in encoding, binding, and retaining information [10, 14, 19, 36, 37]. In keeping with this view, our regression analyses revealed that episodic memory impairment (i.e., RCF 3-min recall) significantly predicted Box Task performance in AD. Additionally, attention (Trails A time) showed a notable trend in its association with task performance. In sum, the observed deficits in visuospatial working memory in both bvFTD and AD appear to reflect the breakdown of distinct, rather than common, cognitive mechanisms [10, 14]. Further investigation, including imaging studies exploring underlying neural substrates, is needed to better understand this topic [6, 9, 38].
To evaluate the diagnostic utility of the Box Task within the context of neuropsychological testing, ROC analyses identified three key measures that accurately distinguished between bvFTD and AD patients: Box Task (6-box between-search error, 6-box within-search error, and 4-box time), RCF 3-min recall, and the ACE-III memory subdomain. Conceptually, the high sensitivity of two visuospatial memory tests and one verbal memory test is not surprising, given the disproportionate impact of AD pathology on visuospatial ability and memory [7, 12, 13, 19]. Tests that evaluate these cognitive skills simultaneously would compound the challenge for AD patients [7, 12, 13, 19]. From a clinical standpoint, accounting for disease severity and overall cognitive capacity becomes imperative when considering a bvFTD versus AD differential diagnosis [31, 39, 40]. To this end, we investigated the effectiveness of the Box Task error measures while considering overall cognitive ability. By combining between-search and within-search errors on the Box Task with the ACE-III total score, our decision tree accurately classified 82% of bvFTD patients and 75% of AD patients. These findings underscore the Box Task’s potential in accurately distinguishing between bvFTD and AD, particularly when considering disease severity and its multiple embedded metrics. Further research, including the establishment of normative data on the Box Task, is required before this test becomes suitable for clinical application.
Finally, focusing on the qualitative aspects of Box Task performance in our cohort, the time taken to complete the task emerged as a strong predictor of AD. Patients with AD consistently spent more time completing the task compared to bvFTD patients across all box set sizes, aligning with clinical observations where AD patients typically exhibit hesitancy and slower performance, while bvFTD patients tend to be more impulsive [10]. We did not, however, observe any discernible differences between the two groups in their strategy approach to the task, as measured by the Levenshtein distance score. It is important to note that the search strategy is likely multidimensional and warrants further investigation. Taken together, our findings contribute to a more nuanced qualitative understanding of these conditions.
While preliminary, our findings carry implications for their application in the clinical setting. Accurate differentiation of clinically probable bvFTD from AD remains challenging, particularly in patients where MRI or corroborative biomarkers are not available [2, 13, 31, 39, 41]. Our study indicates that including targeted tests of visuospatial working memory (Box Task) alongside episodic memory measures (ACE-III memory subscale; RCF 3-min Recall) as part of the diagnostic workup may facilitate the early and accurate identification of these syndromes. Notably, the Box Task offers several advantages over traditional neuropsychological tests: it is brief, easy to administer without extensive training, and measures various cognitive processes (e.g., visuospatial functioning, working memory) by assessing different error types and levels of impairment. Moreover, qualitative aspects such as task completion time and search path strategy provide insights into potential underlying mechanisms contributing to task failure. Nonetheless, it will be important to replicate these findings in a larger cohort and to establish appropriate cut-off scores to ensure the Box Task test is suitable for clinical use.
Similarly, we note several methodological limitations that warrant consideration. First, to increase study power, we combined sporadic and familial bvFTD patients into a single group; however, we acknowledge that memory profiles in this syndrome may vary based on the underlying genetic profile [42]. Second, our study did not include cases with possible bvFTD or atypical variants of FTD or AD. As such, the clinical utility of the Box Task in distinguishing these clinical phenotypes is unknown. The decision to focus on probable bvFTD and typical (i.e., amnestic) AD was grounded in the perceived clarity of their neuropsychological profiles according to current diagnostic criteria. As such, our findings were able to directly challenge current assumptions of the canonical neuropsychological profile of bvFTD. Third, we were not able to include independent biomarker information or confirmation of underlying disease pathology in our study participants. While we recognise the role of biological biomarkers in shaping the future of dementia diagnosis [41], we note that the current diagnostic criteria for bvFTD continue to guide clinical practice, and neuropsychological evaluations for dementia diagnosis are often conducted without access to biomarker data. Fourth, while our AD group was age-matched to the bvFTD group, our AD cohort may primarily represent younger-onset AD (mean age of AD cohort: 66; age range: 53–78), potentially limiting the generalisability of our findings across the entire age spectrum of AD. Fifth, while we used well-accepted measures of memory function, it is not clear how these disturbances relate to subjective experiences of (working) memory lapses in daily life [43]. Further investigation is necessary to arrive at a comprehensive understanding of the relationship between memory impairments as revealed by objective test measures and how these impact the patient in their daily life. Finally, given that apathy is pervasive in bvFTD [44, 45], it will be important to clarify how non-cognitive changes, such as loss of goal-directed behaviour, potentially influence task performance.
In conclusion, this study offers important insights into the visuospatial memory profiles of bvFTD and AD. Our findings reveal significant visuospatial working memory impairment in bvFTD, albeit of lesser severity compared to disease-matched AD patients. Assessments targeting visuospatial memory, including the Box Task, demonstrate promising discriminatory capabilities between bvFTD and AD. Overall, this research underscores the clinical significance of visuospatial memory evaluation in effectively distinguishing between bvFTD and AD.

Acknowledgements

We thank all the participants and their carers for their time and contribution to this study. We acknowledge the statistical assistance of Jim Matthews and Stanislaus Stadlmann from the Sydney Informatics Hub, a Core Research Facility of the University of Sydney. We would also like to thank Dr Max Hinne (ORCID: 0000-0002-9279-6725) for his tremendous help in computing the Box Task normalised Levenshtein edit distance (i.e., strategy) score.

Declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

Human Research Ethics Committee of the South Eastern Sydney Local District, the University of New South Wales, and the University of Sydney (HREC 10/126).
All participants or their person responsible provided written informed consent in accordance with the Declaration of Helsinki.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Neuer Inhalt

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Hornberger M, Piguet O (2012) Episodic memory in frontotemporal dementia: a critical review. Brain 135(Pt 3):678–692PubMedCrossRef Hornberger M, Piguet O (2012) Episodic memory in frontotemporal dementia: a critical review. Brain 135(Pt 3):678–692PubMedCrossRef
2.
Zurück zum Zitat Boeve BF et al (2022) Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. Lancet Neurol 21(3):258–272PubMedCrossRef Boeve BF et al (2022) Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. Lancet Neurol 21(3):258–272PubMedCrossRef
3.
Zurück zum Zitat Poos JM et al (2018) Meta-analytic review of memory impairment in behavioral variant frontotemporal dementia. J Int Neuropsychol Soc 24(6):593–605PubMedPubMedCentralCrossRef Poos JM et al (2018) Meta-analytic review of memory impairment in behavioral variant frontotemporal dementia. J Int Neuropsychol Soc 24(6):593–605PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Rascovsky K et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(Pt 9):2456–2477PubMedPubMedCentralCrossRef Rascovsky K et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(Pt 9):2456–2477PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Irish M et al (2014) Common and unique gray matter correlates of episodic memory dysfunction in frontotemporal dementia and Alzheimer’s disease. Hum Brain Mapp 35(4):1422–1435PubMedCrossRef Irish M et al (2014) Common and unique gray matter correlates of episodic memory dysfunction in frontotemporal dementia and Alzheimer’s disease. Hum Brain Mapp 35(4):1422–1435PubMedCrossRef
7.
Zurück zum Zitat Irish M, Hornberger M (2015) Episodic memory in neurodegenerative disorders: Past, present, and future. The Wiley handbook on the cognitive neuroscience of memory. Wiley Blackwell, Hoboken, pp 415–433CrossRef Irish M, Hornberger M (2015) Episodic memory in neurodegenerative disorders: Past, present, and future. The Wiley handbook on the cognitive neuroscience of memory. Wiley Blackwell, Hoboken, pp 415–433CrossRef
8.
Zurück zum Zitat Salimi S et al (2019) Visuospatial dysfunction in Alzheimer’s disease and behavioural variant frontotemporal dementia. J Neurol Sci 402:74–80PubMedCrossRef Salimi S et al (2019) Visuospatial dysfunction in Alzheimer’s disease and behavioural variant frontotemporal dementia. J Neurol Sci 402:74–80PubMedCrossRef
9.
10.
Zurück zum Zitat Stopford CL et al (2012) Working memory, attention, and executive function in Alzheimer’s disease and frontotemporal dementia. Cortex 48(4):429–446PubMedCrossRef Stopford CL et al (2012) Working memory, attention, and executive function in Alzheimer’s disease and frontotemporal dementia. Cortex 48(4):429–446PubMedCrossRef
11.
Zurück zum Zitat McKhann GM et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):263–269PubMedCrossRef McKhann GM et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):263–269PubMedCrossRef
13.
Zurück zum Zitat Salimi S et al (2018) Can visuospatial measures improve the diagnosis of Alzheimer’s disease? Alzheimers Dement (Amst) 10:66–74PubMedCrossRef Salimi S et al (2018) Can visuospatial measures improve the diagnosis of Alzheimer’s disease? Alzheimers Dement (Amst) 10:66–74PubMedCrossRef
14.
Zurück zum Zitat Stopford CL et al (2010) Working memory in Alzheimer’s disease and frontotemporal dementia. Behav Neurol 23(4):177–179PubMedCrossRef Stopford CL et al (2010) Working memory in Alzheimer’s disease and frontotemporal dementia. Behav Neurol 23(4):177–179PubMedCrossRef
15.
Zurück zum Zitat Baddeley A (2003) Working memory: looking back and looking forward. Nat Rev Neurosci 4(10):829–839PubMedCrossRef Baddeley A (2003) Working memory: looking back and looking forward. Nat Rev Neurosci 4(10):829–839PubMedCrossRef
16.
Zurück zum Zitat Repovs G, Baddeley A (2006) The multi-component model of working memory: explorations in experimental cognitive psychology. Neuroscience 139(1):5–21PubMedCrossRef Repovs G, Baddeley A (2006) The multi-component model of working memory: explorations in experimental cognitive psychology. Neuroscience 139(1):5–21PubMedCrossRef
17.
Zurück zum Zitat Kessels RPC, Postma A (2018) The Box Task: a tool to design experiments for assessing visuospatial working memory. Behav Res Methods 50:1981–1987PubMedCrossRef Kessels RPC, Postma A (2018) The Box Task: a tool to design experiments for assessing visuospatial working memory. Behav Res Methods 50:1981–1987PubMedCrossRef
18.
Zurück zum Zitat van Geldorp B et al (2012) Associative working memory and subsequent episodic memory in Alzheimer’s disease. NeuroReport 23(2):119–123PubMedCrossRef van Geldorp B et al (2012) Associative working memory and subsequent episodic memory in Alzheimer’s disease. NeuroReport 23(2):119–123PubMedCrossRef
19.
Zurück zum Zitat Foxe D et al (2021) The Box Task: a novel tool to differentiate the primary progressive aphasias. Eur J Neurol 28(12):3945–3954PubMedCrossRef Foxe D et al (2021) The Box Task: a novel tool to differentiate the primary progressive aphasias. Eur J Neurol 28(12):3945–3954PubMedCrossRef
21.
Zurück zum Zitat Crutch SJ et al (2017) Consensus classification of posterior cortical atrophy. Alzheimers Dement 13(8):870–884PubMedCrossRef Crutch SJ et al (2017) Consensus classification of posterior cortical atrophy. Alzheimers Dement 13(8):870–884PubMedCrossRef
22.
Zurück zum Zitat Hsieh S et al (2013) Validation of the Addenbrooke’s Cognitive Examination III in frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord 36(3–4):242–250PubMedCrossRef Hsieh S et al (2013) Validation of the Addenbrooke’s Cognitive Examination III in frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord 36(3–4):242–250PubMedCrossRef
23.
Zurück zum Zitat So M et al (2018) Addenbrooke’s Cognitive Examination III: Psychometric characteristics and relations to functional ability in dementia. J Int Neuropsychol Soc 24(8):854–863PubMedCrossRef So M et al (2018) Addenbrooke’s Cognitive Examination III: Psychometric characteristics and relations to functional ability in dementia. J Int Neuropsychol Soc 24(8):854–863PubMedCrossRef
24.
Zurück zum Zitat Wechsler D (1997) Weschler Memory Scale - Third Edition: Administration and Scoring Manual. Psychological Corporation, San Antonio Wechsler D (1997) Weschler Memory Scale - Third Edition: Administration and Scoring Manual. Psychological Corporation, San Antonio
25.
Zurück zum Zitat Reitan RM (1955) The relation of the trail making test to organic brain damage. J Consult Psychol 19(5):393–394PubMedCrossRef Reitan RM (1955) The relation of the trail making test to organic brain damage. J Consult Psychol 19(5):393–394PubMedCrossRef
26.
Zurück zum Zitat Rey A (1941) L’examen psychologique dans les cas d’encéphalopathie traumatique. Archives De Psychologie 28:286–340 Rey A (1941) L’examen psychologique dans les cas d’encéphalopathie traumatique. Archives De Psychologie 28:286–340
27.
Zurück zum Zitat Savage S et al (2013) Distinguishing subtypes in primary progressive aphasia: application of the Sydney language battery. Dement Geriatr Cogn Disord 35(3–4):208–218PubMedCrossRef Savage S et al (2013) Distinguishing subtypes in primary progressive aphasia: application of the Sydney language battery. Dement Geriatr Cogn Disord 35(3–4):208–218PubMedCrossRef
28.
Zurück zum Zitat Gelinas I et al (1999) Development of a functional measure for persons with Alzheimer’s disease: the disability assessment for dementia. Am J Occup Ther 53(5):471–481PubMedCrossRef Gelinas I et al (1999) Development of a functional measure for persons with Alzheimer’s disease: the disability assessment for dementia. Am J Occup Ther 53(5):471–481PubMedCrossRef
29.
Zurück zum Zitat Yujian L, Bo L (2007) A normalized Levenshtein distance metric. IEEE Trans Pattern Anal Mach Intell 29(6):1091–1095PubMedCrossRef Yujian L, Bo L (2007) A normalized Levenshtein distance metric. IEEE Trans Pattern Anal Mach Intell 29(6):1091–1095PubMedCrossRef
30.
Zurück zum Zitat Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol) 57(1):289–300CrossRef Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol) 57(1):289–300CrossRef
31.
Zurück zum Zitat Dermody N et al (2016) Prospective memory impairments in Alzheimer’s disease and behavioral variant frontotemporal dementia: clinical and neural correlates. J Alzheimers Dis 50(2):425–441PubMedCrossRef Dermody N et al (2016) Prospective memory impairments in Alzheimer’s disease and behavioral variant frontotemporal dementia: clinical and neural correlates. J Alzheimers Dis 50(2):425–441PubMedCrossRef
32.
Zurück zum Zitat Piguet O, Kumfor F, Hodges J (2017) Diagnosing, monitoring and managing behavioural variant frontotemporal dementia. Med J Aust 207(7):303–308PubMedCrossRef Piguet O, Kumfor F, Hodges J (2017) Diagnosing, monitoring and managing behavioural variant frontotemporal dementia. Med J Aust 207(7):303–308PubMedCrossRef
33.
Zurück zum Zitat Zimmer HD (2008) Visual and spatial working memory: from boxes to networks. Neurosci Biobehav Rev 32(8):1373–1395PubMedCrossRef Zimmer HD (2008) Visual and spatial working memory: from boxes to networks. Neurosci Biobehav Rev 32(8):1373–1395PubMedCrossRef
34.
Zurück zum Zitat Quinn JG (2008) Movement and visual coding: the structure of visuo-spatial working memory. Cogn Process 9(1):35–43PubMedCrossRef Quinn JG (2008) Movement and visual coding: the structure of visuo-spatial working memory. Cogn Process 9(1):35–43PubMedCrossRef
35.
Zurück zum Zitat Baddeley A (2012) Working memory: theories, models, and controversies. Annu Rev Psychol 63:1–29PubMedCrossRef Baddeley A (2012) Working memory: theories, models, and controversies. Annu Rev Psychol 63:1–29PubMedCrossRef
36.
Zurück zum Zitat Kessels RPC, Bergmann HC (2022) What does the hippocampus do during working-memory tasks? A cognitive-neuropsychological perspective. Cogn Neurosci 13(3–4):210–211PubMedCrossRef Kessels RPC, Bergmann HC (2022) What does the hippocampus do during working-memory tasks? A cognitive-neuropsychological perspective. Cogn Neurosci 13(3–4):210–211PubMedCrossRef
37.
Zurück zum Zitat Foxe D et al (2016) The neural correlates of auditory and visuospatial span in logopenic progressive aphasia and Alzheimer’s disease. Cortex 83:39–50PubMedCrossRef Foxe D et al (2016) The neural correlates of auditory and visuospatial span in logopenic progressive aphasia and Alzheimer’s disease. Cortex 83:39–50PubMedCrossRef
38.
Zurück zum Zitat van Geldorp B et al (2015) Working memory binding and episodic memory formation in aging, mild cognitive impairment, and Alzheimer’s dementia. J Clin Exp Neuropsychol 37(5):538–548PubMedCrossRef van Geldorp B et al (2015) Working memory binding and episodic memory formation in aging, mild cognitive impairment, and Alzheimer’s dementia. J Clin Exp Neuropsychol 37(5):538–548PubMedCrossRef
39.
Zurück zum Zitat Frisch S et al (2013) Dissociating memory networks in early Alzheimer’s disease and frontotemporal lobar degeneration—a combined study of hypometabolism and atrophy. PLoS ONE 8(2):e55251PubMedPubMedCentralCrossRef Frisch S et al (2013) Dissociating memory networks in early Alzheimer’s disease and frontotemporal lobar degeneration—a combined study of hypometabolism and atrophy. PLoS ONE 8(2):e55251PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Musa G et al (2020) Alzheimer’s disease or behavioral variant frontotemporal dementia? review of key points toward an accurate clinical and neuropsychological diagnosis. J Alzheimers Dis 73(3):833–848PubMedPubMedCentralCrossRef Musa G et al (2020) Alzheimer’s disease or behavioral variant frontotemporal dementia? review of key points toward an accurate clinical and neuropsychological diagnosis. J Alzheimers Dis 73(3):833–848PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Ranasinghe KG et al (2016) Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage. Neurology 86(7):600–610PubMedPubMedCentralCrossRef Ranasinghe KG et al (2016) Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage. Neurology 86(7):600–610PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Del Campo M et al (2022) New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia. Alzheimers Dement 18(11):2292–2307PubMedCrossRef Del Campo M et al (2022) New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia. Alzheimers Dement 18(11):2292–2307PubMedCrossRef
43.
Zurück zum Zitat Irish M et al (2013) Neural substrates of episodic memory dysfunction in behavioural variant frontotemporal dementia with and without C9ORF72 expansions. Neuroimage Clin 2:836–843PubMedPubMedCentralCrossRef Irish M et al (2013) Neural substrates of episodic memory dysfunction in behavioural variant frontotemporal dementia with and without C9ORF72 expansions. Neuroimage Clin 2:836–843PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Liu L et al (2021) Examining prefrontal contributions to past- and future-oriented memory disturbances in daily life in dementia. Cortex 134:307–319PubMedCrossRef Liu L et al (2021) Examining prefrontal contributions to past- and future-oriented memory disturbances in daily life in dementia. Cortex 134:307–319PubMedCrossRef
45.
Zurück zum Zitat Shaw SR et al (2021) Uncovering the prevalence and neural substrates of anhedonia in frontotemporal dementia. Brain 144(5):1551–1564PubMedCrossRef Shaw SR et al (2021) Uncovering the prevalence and neural substrates of anhedonia in frontotemporal dementia. Brain 144(5):1551–1564PubMedCrossRef
46.
Zurück zum Zitat Kumfor F et al (2018) Apathy in Alzheimer’s disease and frontotemporal dementia: Distinct clinical profiles and neural correlates. Cortex 103:350–359PubMedCrossRef Kumfor F et al (2018) Apathy in Alzheimer’s disease and frontotemporal dementia: Distinct clinical profiles and neural correlates. Cortex 103:350–359PubMedCrossRef
Metadaten
Titel
Visuospatial working memory in behavioural variant frontotemporal dementia: a comparative analysis with Alzheimer's disease using the box task
verfasst von
David Foxe
Muireann Irish
James Carrick
Sau Chi Cheung
Her Teng
James R. Burrell
Roy P. C. Kessels
Olivier Piguet
Publikationsdatum
07.05.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-024-12406-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.